Podcasts about ob gyn dr

Send us a textIn this deeply clarifying conversation, Functional Nutritionist Janel Anderson sits down with OB-GYN Dr. Howard for the kind of honest, nuanced midlife hormone talk every woman deserves. Together, they unpack what's really happening in perimenopause and menopause, why symptoms vary so wildly, how medical understanding has changed dramatically in the last decade, and what today's research actually says about hormone therapy. Dr. Howard breaks down the timing of HRT, the difference between systemic estradiol and vaginal estrogen, why progesterone matters, where testosterone fits in, and how to know what's right for your unique biology. This is a validating, myth-busting, empowering conversation that helps women understand their bodies and advocate for the care they deserve.Is hormone therapy necessary for every woman to feel her best? Have a listen and find out what Dr Howard and I think

Dr. Linda Duska and Dr. Kathleen Moore discuss key studies in the evolving controversy over radical upfront surgery versus neoadjuvant chemotherapy in advanced ovarian cancer. TRANSCRIPT Dr. Linda Duska: Hello, and welcome to the ASCO Daily News Podcast. I am your guest host, Dr. Linda Duska. I am a professor of obstetrics and gynecology at the University of Virginia School of Medicine.  On today's episode, we will explore the management of advanced ovarian cancer, specifically with respect to a question that has really stirred some controversy over time, going all the way back more than 20 years: Should we be doing radical upfront surgery in advanced ovarian cancer, or should we be doing neoadjuvant chemotherapy? So, there was a lot of hype about the TRUST study, also called ENGOT ov33/AGO-OVAR OP7, a Phase 3 randomized study that compares upfront surgery with neoadjuvant chemotherapy followed by interval surgery. So, I want to talk about that study today. And joining me for the discussion is Dr. Kathleen Moore, a professor also of obstetrics and gynecology at the University of Oklahoma and the deputy director of the Stephenson Cancer Center, also at the University of Oklahoma Health Sciences.  Dr. Moore, it is so great to be speaking with you today. Thanks for doing this. Dr. Kathleen Moore: Yeah, it's fun to be here. This is going to be fun. Dr. Linda Duska: FYI for our listeners, both of our full disclosures are available in the transcript of this episode.  So let's just jump right in. We already alluded to the fact that the TRUST study addresses a question we have been grappling with in our field. Here's the thing, we have four prior randomized trials on this exact same topic. So, share with me why we needed another one and what maybe was different about this one? Dr. Kathleen Moore: That is, I think, the key question. So we have to level-set kind of our history. Let's start with, why is this even a question? Like, why are we even talking about this today? When we are taking care of a patient with newly diagnosed ovarian cancer, the aim of surgery in advanced ovarian cancer ideally is to prolong a patient's likelihood of disease-free survival, or if you want to use the term "remission," you can use the term "remission." And I think we can all agree that our objective is to improve overall survival in a way that also does not compromise her quality of life through surgical complications, which can have a big effect. The standard for many decades, certainly my entire career, which is now over 20 years, has been to pursue what we call primary cytoreductive surgery, meaning you get a diagnosis and we go right to the operating room with a goal of achieving what we call "no gross residual." That is very different – in the olden days, you would say "optimal" and get down to some predefined small amount of tumor. Now, the goal is you remove everything you can see.  The alternative strategy to that is neoadjuvant chemotherapy followed by interval cytoreductive surgery, and that has been the, quote-unquote, "safer" route because you chemically cytoreduce the cancer, and so, the resulting surgery, I will tell you, is not necessarily easy at all. It can still be very radical surgeries, but they tend to be less radical, less need for bowel resections, splenectomy, radical procedures, and in a short-term look, would be considered safer from a postoperative consideration. Dr. Linda Duska: Well, and also maybe more likely to be successful, right? Because there's less disease, maybe, theoretically. Dr. Kathleen Moore: More likely to be successful in getting to no gross residual. Dr. Linda Duska: Right. Yeah, exactly. Dr. Kathleen Moore: I agree with that. And so, so if the end game, regardless of timing, is you get to no gross residual and you help a patient and there's no difference in overall survival, then it's a no-brainer. We would not be having this conversation. But there remains a question around, while it may be more likely to get to no gross residual, it may be, and I think we can all agree, a less radical, safer surgery, do you lose survival in the long term by this approach? This has become an increasing concern because of the increase in rates of use of neoadjuvant, not only in this country, but abroad. And so, you mentioned the four prior studies. We will not be able to go through them completely. Dr. Linda Duska: Let's talk about the two modern ones, the two from 2020 because neither one of them showed a difference in overall survival, which I think we can agree is, at the end of the day, yes, PFS would be great, but OS is what we're looking for. Dr. Kathleen Moore: OS is definitely what we're looking for. I do think a marked improvement in PFS, like a real prolongation in disease-free survival, for me would be also enough. A modest improvement does not really cut it, but if you are really, really prolonging PFS, you should see that-  Dr. Linda Duska: -manifest in OS. Dr. Kathleen Moore: Yeah, yeah. Okay. So let's talk about the two modern ones. The older ones are EORTC and CHORUS, which I think we've talked about. The two more modern ones are SCORPION and JCOG0602. So, SCORPION was interesting. SCORPION was a very small study, though. So one could say it's underpowered. 170 patients. And they looked at only patients that were incredibly high risk. So, they had to have a Fagotti score, I believe, of over 9, but they were not looking at just low volume disease. Like, those patients were not enrolled in SCORPION. It was patients where you really were questioning, "Should I go to the OR or should I do neoadjuvant? Like, what's the better thing?" It is easy when it's low volume. You're like, "We're going." These were the patients who were like, "Hm, you know, what should I do?" High volume. Patients were young, about 55. The criticism of the older studies, there are many criticisms, but one of them is that, the criticism that is lobbied is that they did not really try. Whatever surgery you got, they did not really try with median operative times of 180 minutes for primary cytoreduction, 120 for neoadjuvant. Like, you and I both know, if you're in a big primary debulking, you're there all day. It's 6 hours. Dr. Linda Duska: Right, and there was no quality control for those studies, either. Dr. Kathleen Moore: No quality control. So, SCORPION, they went 451-minute median for surgery. Like, they really went for it versus four hours and then 253 for the interval, 4 hours. They really went for it on both arms. Complete gross resection was achieved in 50% of the primary cytoreduced. So even though they went for it with these very long surgeries, they only got to the goal half the time. It was almost 80% in the interval group. So they were more successful there. And there was absolutely no difference in PFS or OS. They were right about 15 months PFS, right about 40 months OS.  JCOG0602, of course, done in Japan, a big study, 300 patients, a little bit older population. Surprisingly more stage IV disease in this study than were in SCORPION. SCORPION did not have a lot of stage IV, despite being very bulky tumors. So a third of patients were stage IV. They also had relatively shorter operative times, I would say, 240 minutes for primary, 302 for interval. So still kind of short. Complete gross resection was not achieved very often. 30% of primary cytoreduction. That is not acceptable. Dr. Linda Duska: Well, so let's talk about TRUST. What was different about TRUST? Why was this an important study for us to see? Dr. Kathleen Moore: So the criticism of all of these, and I am not trying to throw shade at anyone, but the criticism of all of these is if you are putting surgery to the test, you are putting the surgeon to the test. And you are assuming that all surgeons are trained equally and are willing to do what it takes to get someone to no gross residual. Dr. Linda Duska: And are in a center that can support the post-op care for those patients. Dr. Kathleen Moore: Which can be ICU care, prolonged time. Absolutely. So when you just open these broadly, you're assuming everyone has the surgical skills and is comfortable doing that and has backup. Everybody has an ICU. Everyone has a blood bank, and you are willing to do that. And that assumption could be wrong. And so what TRUST said is, "Okay, we are only going to open this at centers that have shown they can achieve a certain level of primary cytoreduction to no gross residual disease." And so there was quality criteria. It was based on – it was mostly a European study – so ESGO criteria were used to only allow certified centers to participate. They had to have a surgical volume of over 36 cytoreductive surgeries per year. So you could not be a low volume surgeon. Your complete resection rates that were reported had to be greater than 50% in the upfront setting. I told you on the JCOG, it was 30%. Dr. Linda Duska: Right. So these were the best of the best. This was the best possible surgical situation you could put these patients in, right? Dr. Kathleen Moore: Absolutely. And you support all the things so you could mitigate postoperative complications as well. Dr. Linda Duska: So we are asking the question now again in the ideal situation, right? Dr. Kathleen Moore: Right. Dr. Linda Duska: Which, we can talk about, may or may not be generalizable to real life, but that's a separate issue because we certainly don't have those conditions everywhere where people get cared for with ovarian cancer. But how would you interpret the results of this study? Did it show us anything different? Dr. Kathleen Moore: I am going to say how we should interpret it and then what I am thinking about. It is a negative study. It was designed to show improvement in overall survival in these ideal settings in patients with FIGO stage IIIB and C, they excluded A, these low volume tumors that should absolutely be getting surgery. So FIGO stage IIIB and C and IVA and B that were fit enough to undergo radical surgery randomized to primary cytoreduction or neoadjuvant with interval, and were all given the correct chemo. Dr. Linda Duska: And they were allowed bevacizumab and PARP, also. They could have bevacizumab and PARP. Dr. Kathleen Moore: They were allowed bevacizumab and PARP. Not many of them got PARP, but it was distributed equally, so that would not be a confounder. And so that was important. Overall survival is the endpoint. It was a big study. You know, it was almost 600 patients. So appropriately powered. So let's look at what they reported. When they looked at the patients who were enrolled, this is a large study, almost 600 patients, 345 in the primary cytoreductive arm and 343 in the neoadjuvant arm. Complete resection in these patients was 70% in the primary cytoreductive arm and 85% in the neoadjuvant arm. So in both arms, it was very high. So your selection of site and surgeon worked. You got people to their optimal outcome. So that is very different than any other study that has been reported to date. But what we saw when we looked at overall survival was no statistical difference. The median was, and I know we do not like to talk about medians, but the median in the primary cytoreductive arm was 54 months versus 48 months in the neoadjuvant arm with a hazard ratio of 0.89 and, of course, the confidence interval crossed one. So this is not statistically significant. And that was the primary endpoint. Dr. Linda Duska: I know you are getting to this. They did look at PFS, and that was statistically significant, but to your point about what are we looking for for a reasonable PFS difference? It was about two months difference. When I think about this study, and I know you are coming to this, what I thought was most interesting about this trial, besides the fact that the OS, the primary endpoint was negative, was the subgroup analyses that they did. And, of course, these are hypothesis-generating only. But if you look at, for example, specifically only the stage III group, that group did seem to potentially, again, hypothesis generating, but they did seem to benefit from upfront surgery.  And then one other thing that I want to touch on before we run out of time is, do we think it matters if the patient is BRCA germline positive? Do we think it matters if there is something in particular about that patient from a biomarker standpoint that is different? I am hopeful that more data will be coming out of this study that will help inform this. Of course, unpowered, hypothesis-generating only, but it's just really interesting. What do you think of their subset analysis? Dr. Kathleen Moore: Yeah, I think the subsets are what we are going to be talking about, but we have to emphasize that this was a negative trial as designed. Dr. Linda Duska: Absolutely. Yes. Dr. Kathleen Moore: So we cannot be apologists and be like, "But this or that." It was a negative trial as designed. Now, I am a human and a clinician, and I want what is best for my patients. So I am going to, like, go down the path of subset analyses. So if you look at the stage III tumors that got complete cytoreduction, which was 70% of the cases, your PFS was almost 28 months versus 21.8 months. Dr. Linda Duska: Yes, it becomes more significant. Dr. Kathleen Moore: Yeah, that hazard ratio is 0.69. Again, it is a subset. So even though the P value here is statistically significant, it actually should not have a P value because it is an exploratory analysis. So we have to be very careful. But the hazard ratio is 0.69. So the hypothesis is in this setting, if you're stage III and you go for it and you get someone to no gross residual versus an interval cytoreduction, you could potentially have a 31% reduction in the rate of progression for that patient who got primary cytoreduction. And you see a similar trend in the stage III patients, if you look at overall survival, although the post-progression survival is so long, it's a little bit narrow of a margin.  But I do think there are some nuggets here that, one of our colleagues who is really one of the experts in surgical studies, Dr. Mario Leitao, posted this on X, and I think it really resonated after this because we were all saying, "But what about the subsets?" He is like, "It's a negative study." But at the end of the day, you are going to sit with your patient. The patient should be seen by a GYN oncologist or surgical oncologist with specialty in cytoreduction and a medical oncologist, you know, if that person does not give chemo, and the decision should be made about what to do for that individual patient in that setting. Dr. Linda Duska: Agreed. And along those lines, if you look carefully at their data, the patients who had an upfront cytoreduction had almost twice the risk of having a stoma than the patients who had an interval cytoreduction. And they also had a higher risk of needing to have a bowel resection. The numbers were small, but still, when you look at the surgical complications, as you've already said, they're higher in the upfront group than they are in the interval group. That needs to be taken into account as well when counseling a patient, right? When you have a patient in front of you who says to you, "Dr. Moore, you can take out whatever you want, but whatever you do, don't make me a bag." As long as the patient understands what that means and what they're asking us to do, I think that we need to think about that. Dr. Kathleen Moore: I think that is a great point. And I have definitely seen in our practice, patients who say, "I absolutely would not want an ostomy. It's a nonstarter for me." And we do make different decisions. And you have to just say, "That's the decision we've made," and you kind of move on, and you can't look back and say, "Well, I wish I would have, could have, should have done something else." That is what the patient wants. Ultimately, that patient, her family, autonomous beings, they need to be fully counseled, and you need to counsel that patient as to the site that you are in, her volume of disease, and what you think you can achieve. In my opinion, a patient with stage III cancer who you have the site and the capabilities to get to no gross residual should go to the OR first. That is what I believe. I do not anymore think that for stage IV. I think that this is pretty convincing to me that that is probably a harmful thing. However, I want you to react to this. I think I am going to be a little unpopular in saying this, but for me, one of the biggest take-homes from TRUST was that whether or not, and we can talk about the subsets and the stage III looked better, and I think it did, but both groups did really well. Like, really well. And these were patients with large volume disease. This was not cherry-picked small volume stage IIIs that you could have done an optimal just by doing a hysterectomy. You know, these were patients that needed radical surgery. And both did well. And so what it speaks to me is that anytime you are going to operate on someone with ovary, whether it be frontline, whether it be a primary or interval, you need a high-volume surgeon. That is what I think this means to me. Like, I would want high volume surgeon at a center that could do these surgeries, getting that patient, my family member, me, to no gross residual. That is important. And you and I are both in training centers. I think we ought to take a really strong look at, are we preparing people to do the surgeries that are necessary to get someone to no gross residual 70% and 85% of the time? Dr. Linda Duska: We are going to run out of time, but I want to address that and ask you a provocative question. So, I completely agree with what you said, that surgery is important. But I also think one of the reasons these patients in this study did so well is because all of the incredible new therapies that we have for patients. Because OS is not just about surgery. It is about surgery, but it is also about all of the amazing new therapies we have that you and others have helped us to get through clinical research. And so, how much of that do you think, like, for example, if you look at the PFS and OS rates from CHORUS and EORTC, I get it that they're, that they're not the same. It's different patients, different populations, can't do cross-trial comparisons. But the OS, as you said, in this study was 54 months and 48 months, which is, compared to 2010, we're doing much, much better. It is not just the surgery, it is also all the amazing treatment options we have for these patients, including PARP, including MIRV, including lots of other new therapies. How do you fit that into thinking about all of this? Dr. Kathleen Moore: I do think we are seeing, and we know this just from epidemiologic data that the prevalence of ovarian cancer in many of the countries where the study was done is increasing, despite a decrease in incidence. And why is that? Because people are living longer. Dr. Linda Duska: People are living longer, yeah. Dr. Kathleen Moore: Which is phenomenal. That is what we want. And we do have, I think, better supportive care now. PARP inhibitors in the frontline, which not many of these patients had. Now some of them, this is mainly in Europe, will have gotten them in the first maintenance setting, and I do think that impacts outcome. We do not have that data yet, you know, to kind of see what, I would be really interested to see. We do not do this well because in ovarian cancer, post-progression survival can be so long, we do not do well of tracking what people get when they come off a clinical trial to see how that could impact – you know, how many of them got another surgery? How many of them got a PARP? I think this group probably missed the ADC wave for the most part, because this, mirvetuximab is just very recently available in Europe. Dr. Linda Duska: Unless they were on trial. Dr. Kathleen Moore: Unless they were on trial. But I mean, I think we will have to see. 600 patients, I would bet a lot of them missed the ADC wave. So, I do not know that we can say we know what drove these phenomenal – these are some of the best curves we've seen outside of BRCA. And then coming back to your point about the BRCA population here, that is a really critical question that I do not know that we're ever going to answer. There have been hypotheses around a tumor that is driven by BRCA, if you surgically cytoreduced it, and then chemically cytoreduced it with chemo, and so you're starting PARP with nothing visible and likely still homogeneous clones. Is that the group we cured? And then if you give chemo first before surgery, it allows more rapid development of heterogeneity and more clonal evolution that those are patients who are less likely to be cured, even if they do get cytoreduced to nothing at interval with use of PARP inhibitor in the front line. That is a question that many have brought up as something we would like to understand better. Like, if you are BRCA, should you always just go for it or not? I do not know that we're ever going to really get to that. We are trying to look at some of the other studies and just see if you got neoadjuvant and you had BRCA, was anyone cured? I think that is a question on SOLO1 I would like to know the answer to, and I don't yet, that may help us get to that. But that's sort of something we do think about. You should have a fair number of them in TRUST. It wasn't a stratification factor, as I remember. Dr. Linda Duska: No, it wasn't. They stratified by center, age, and ECOG status Dr. Kathleen Moore: So you would hope with randomization that you would have an equal number in each arm. And they may be able to pull that out and do a very exploratory look. But I would be interested to see just completely hypothesis-generating what this looks like for the patients with BRCA, and I hope that they will present that. I know they're busy at work. They have translational work. They have a lot pending with TRUST. It's an incredibly rich resource that I think is going to teach us a lot, and I am excited to see what they do next. Dr. Linda Duska: So, outside of TRUST, we are out of time. I just want to give you a moment if there were any other messages that you want to share with our listeners before we wrap up. Dr. Kathleen Moore: It's an exciting time to be in GYN oncology. For so long, it was just chemo, and then the PARP inhibitors nudged us along quite a bit. We did move more patients, I believe, to the cure fraction. When we ultimately see OS, I think we'll be able to say that definitively, and that is exciting. But, you know, that is the minority of our patients. And while HRD positive benefits tremendously from PARP, I am not as sure we've moved as many to the cure fraction. Time will tell. But 50% of our patients have these tumors that are less HRD. They have a worse prognosis. I think we can say that and recur more quickly. And so the advent of these antibody-drug conjugates, and we could name 20 of them in development in GYN right now, targeting tumor-associated antigens because we're not really driven by mutations other than BRCA. We do not have a lot of things to come after. We're not lung cancer. We are not breast cancer. But we do have a lot of proteins on the surface of our cancers, and we are finally able to leverage that with some very active regimens. And we're in the early phases, I would say, of really understanding how best to use those, how best to position them, and which one to select for whom in a setting where there is going to be obvious overlap of the targets. So we're going to be really working this problem. It is a good problem. A lot of drugs that work pretty well. How do you individualize for a patient, the patient in front of you with three different markers? How do you optimize it? Where do you put them to really prolong survival? And then we finally have cell surface. We saw at ASCO, CDK2 come into play here for the first time, we've got a cell cycle inhibitor. We've been working on WEE1 and ATR for a long time. CDK2s may hit. Response rates were respectable in a resistant population that was cyclin E overexpressing. We've been working on that biomarker for a long time with a toxicity profile that was surprisingly clean, which I like to see for our patients. So that is a different platform. I think we have got bispecifics on the rise. So there is a pipeline of things behind the ADCs, which is important because we need more than one thing, that makes me feel like in the future, I am probably not going to be using doxil ever for platinum-resistant disease. So, I am going to be excited to retire some of those things. We will say, "Remember when we used to use doxil for platinum-resistant disease?" Dr. Linda Duska: I will be retired by then, but thanks for that thought. Dr. Kathleen Moore: I will remind you. Dr. Linda Duska: You are right. It is such an incredibly exciting time to be taking care of ovarian cancer patients with all the opportunities.  And I want to thank you for sharing your valuable insights with us on this podcast today and for your great work to advance care for patients with GYN cancers. Dr. Kathleen Moore: Likewise. Thanks for having me. Dr. Linda Duska: And thank you to our listeners for your time today. You will find links to the TRUST study and other studies discussed today in the transcript of this episode. Finally, if you value the insights that you hear on the ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. More on today's speakers:   Dr. Linda Duska  @Lduska Dr. Kathleen Moore Follow ASCO on social media:     @ASCO on X (formerly Twitter) ASCO on Bluesky   ASCO on Facebook     ASCO on LinkedIn     Disclosures of Potential Conflicts of Interest:    Dr. Linda Duska:   Consulting or Advisory Role: Regeneron, Inovio Pharmaceuticals, Merck, Ellipses Pharma  Research Funding (Inst.): GlaxoSmithKline, Millenium, Bristol-Myers Squibb, Aeterna Zentaris, Novartis, Abbvie, Tesaro, Cerulean Pharma, Aduro Biotech, Advaxis, Ludwig Institute for Cancer Research, Leap Therapeutics  Patents, Royalties, Other Intellectual Property: UptToDate, Editor, British Journal of Ob/Gyn  Dr. Kathleen Moore: Leadership: GOG Partners, NRG Ovarian Committee Chair Honoraria: Astellas Medivation, Clearity Foundation, IDEOlogy Health, Medscape, Great Debates and Updates, OncLive/MJH Life Sciences, MD Outlook, Curio Science, Plexus, University of Florida, University of Arkansas for Medical Sciences, Congress Chanel, BIOPHARM, CEA/CCO, Physician Education Resource (PER), Research to Practice, Med Learning Group, Peerview, Peerview, PeerVoice, CME Outfitters, Virtual Incision Consulting/Advisory Role: Genentech/Roche, Immunogen, AstraZeneca, Merck, Eisai, Verastem/Pharmacyclics, AADi, Caris Life Sciences, Iovance Biotherapeutics, Janssen Oncology, Regeneron, zentalis, Daiichi Sankyo Europe GmbH, BioNTech SE, Immunocore, Seagen, Takeda Science Foundation, Zymeworks, Profound Bio, ADC Therapeutics, Third Arc, Loxo/Lilly, Bristol Myers Squibb Foundation, Tango Therapeutics, Abbvie, T Knife, F Hoffman La Roche, Tubulis GmbH, Clovis Oncology, Kivu, Genmab/Seagen, Kivu, Genmab/Seagen, Whitehawk, OnCusp Therapeutics, Natera, BeiGene, Karyopharm Therapeutics, Day One Biopharmaceuticals, Debiopharm Group, Foundation Medicine, Novocure Research Funding (Inst.): Mersana, GSK/Tesaro, Duality Biologics, Mersana, GSK/Tesaro, Duality Biologics, Merck, Regeneron, Verasatem, AstraZeneca, Immunogen, Daiichi Sankyo/Lilly, Immunocore, Torl Biotherapeutics, Allarity Therapeutics, IDEAYA Biosciences, Zymeworks, Schrodinger Other Relationship (Inst.): GOG Partners

Book a Discovery Call for Relationship Renovation CoachingOr email us directly at coaching@relationshiprenovation.com with the subject line “Couples Coaching Application.” Order Relationship Renovation at Home Manual from AmazonJoin Our Patreon CommunityTake the Emotional Safety Assessment QuizIn this episode of the Relationship Renovation Podcast, hosts EJ and Tarah Kerwin sit down with renowned OB/GYN Dr. Maria Sophocles to unpack the truth about menopause, hormones, and how they shape sexual health, intimacy, and relationship wellness. With nearly three decades of experience and a global reputation for advancing women's care, Dr. Sophocles sheds light on why so many women feel unseen and unsupported during perimenopause, low libido, and the “bedroom gap” that can grow between partners in midlife.The conversation blends science, empathy, and practical solutions—covering everything from hormone replacement therapy (HRT) and CO₂ laser treatments to the emotional impact of hormonal shifts and the cultural “pink tax” on women's wellness.Whether you're a woman navigating change, a partner trying to understand, or a couple feeling distant, this episode offers hope, clarity, and tools to rebuild connection, safety, and vibrant intimacy. Listen in and feel empowered to advocate for your body, your pleasure, and your relationship.Support this podcast at — https://redcircle.com/he-said-she-said/donationsAdvertising Inquiries: https://redcircle.com/brands

In this special role-reversal episode, Beth hands the mic to her longtime friend of 40+ years, OB-GYN Dr. Patricia “Tricia” McClelland—a familiar voice on the podcast from past episodes on hormones and menopause. This time, Tricia interviews Beth, asking the questions Beth usually asks everyone else. Together they dive into the values that quietly steer Beth's life—love, kindness, community, authenticity, using your gifts to help others, and treating everyone with dignity—plus how her Christian faith gives her peace with her own imperfections. Beth opens up about parenting three kids close together, her journey with ADHD, and how chronic people-pleasing and weak boundaries left her exhausted (and what she's doing differently now). They talk honestly about: Growing through hard seasons like early motherhood How ADHD shows up as procrastination, overwhelm, and “inconsistent attention” Practical tools for focus in a distracted, social-media-driven world Boundaries, FOMO, and the myth that you can keep everyone happy Food, body image, and talking to kids about health without shame Self-care that actually fits real life: yoga, friendship, faith, and small doable practices If you've ever felt like you're supposed to have it all together while secretly struggling, this conversation will make you feel seen, normal, and a little more hopeful.

OBGYN Dr. Elizabeth Elfstrand joins Jordana to talk about hormone replacement for menopause.

In this urgent and eye-opening conversation, practicing OB/GYN Dr. Ingrid Skop, Medical Director of the Charlotte Lozier Institute, joins the show to expose the hidden medical realities behind chemical abortions — and the dangers that many women are never told. As the FDA quietly authorizes a new generic abortion pill, Dr. Skop brings decades of frontline experience to explain what's really happening inside emergency rooms across the country.From understanding how mifepristone and misoprostol work in the body to uncovering complications often misreported as miscarriages, this episode separates politics from science to focus on what truly matters — women's health and safety.Listeners will hear:What happens medically during a chemical abortion — and how it differs from surgical procedures.The most common complications ER doctors are seeing and why they're often undocumented.Why ultrasound screenings and accurate data reporting are essential for patient protection.What steps medical professionals can take to better recognize and treat abortion drug complications.How to recognize warning signs that require immediate medical attention.This is not a debate — it's a medical conversation every woman deserves to hear.https://lozierinstitute.org/team-member/ingrid-skop-m-d-facog/Become a supporter of this podcast: https://www.spreaker.com/podcast/i-am-refocused-radio--2671113/support.Thank you for tuning in to I Am Refocused Radio. For more inspiring conversations, visit IAmRefocusedRadio.com and stay connected with our community.Don't miss new episodes—subscribe now at YouTube.com/@RefocusedRadioThank you for your time. 

We are joined by OBGYN Dr. Van Beek to talk women's health, menipause, sexual health, and answering some of your most asked questions!

Did you know there's a trillion-dollar gender gap in healthcare research—and it's leaving women in midlife at a disadvantage when it comes to sexual health, hormones, and overall wellbeing? On this episode of The Period Whisperer Podcast, I sit down with Dr. Maria Sophocles, board-certified OBGYN, women's health advocate, and viral TED speaker, to tackle the “bedroom gap” in perimenopause and menopause.We discuss why women's sexual health is under-researched, how hormonal shifts in midlife impact libido, intimacy, and pleasure, and what women can actually do to close the gap and reclaim a fulfilling sex life. As a menopause and sexual health expert, I bring evidence-based guidance, separating fact from fear so women can take charge of their hormonal health and intimacy.Key Takeaways:The gendered healthcare gap: why women are underrepresented in research and how it impacts sexual health in midlife.Understanding the bedroom gap in perimenopause and menopause, including the hormonal and physiological factors involved.Actionable strategies women can use to boost libido, intimacy, and confidence, even in midlife.If you're ready to understand your body, reclaim your sexual health, and close the bedroom gap, this episode is packed with insight, education, and empowerment.➡️ Ready to feel like a 10 again?Book a call to discover your personalized path back to deep sleep, steady energy, and hormonal harmony in a body that you love. Learn More From Maria Here:Instagram: @mariasophoclesmd Website: mariasophoclesmd.comTed Talk: https://www.ted.com/talks/maria_sophocles_what_happens_to_sex_in_midlife_a_look_at_the_bedroom_gap The Bedroom Gap Book

Candace and OB-GYN Dr. Tabatha Barber go straight into one of the biggest mysteries of midlife: perimenopause. Together they unpack what menopause really is (one single day after 12 months without a period) and why today's hormonal chaos—hot flashes, brain fog, mood swings, and “food noise”—often comes from stress, gut health, and toxins more than from age alone. Dr. Tabatha explains how cortisol, gut bacteria, and liver overload can throw the whole system off, while Candace opens up about her own journey toward balance and breaking the sugar cycle. The two also discuss renewing the mind with Scripture, practical toxin swaps, smarter lab work, and how to pursue fitness without letting it rule your identity. Calls to Action: • Download the free Whole Body Guide to follow this season's journey — available now at Candace.com (link in show notes)• Ask a question for a future episode at Candace.com (Questions)• Join the Together Community for private podcast discussions — Candace.com/together• Get tour tickets for Candace's live events (Nov 20–23) — Candace.com/tour Follow Dr. Tabatha on Socials IG @gutsydrtabatha YouTube: https://www.youtube.com/c/TheGutsyGynecologist https://drtabatha.com/about/ Sponsors For This Episode -Truth and Treason: angel.com/candace -Nuethix: ⁠https://nuethix.com/⁠ Use code CANDACE -WeShare: https://www.weshare.org/candace -IFCJ http://IFCJ.org - Operation Christmas Child SamaritansPurse.org/occ Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode, Dr. Sadaf welcomes board-certified OB-GYN Dr. Jamil Abdur-Rahman from Chicago, to discuss everything you need to know about the life of an Obstetrician/Gynecologist! Dr. Abdur-Rahman shares his expertise on the life of a career OB-GYN, as well as the absolutely fascinating story of how he and his identical twin brother both got into the profession. In addition to discussing how he and his brother work to not only help women through their practice, Dr. Abdur-Rahman also explains their mission to expose misconceptions about health through their work on their own podcast and on TV. Disclaimer: Anything discussed on the show should not be taken as official medical advice. If you have any concerns about your health, please speak to your medical provider. If you have any questions about your religion, please ask your friendly neighborhood religious leader. It's the Muslim Sex Podcast because I just happen to be a Muslim woman who talks about sex.To learn more about Dr. Sadaf's practice and to become a patient visit DrSadaf.comLike and subscribe to our YouTube channel where you can watch all episodes of the podcast!Feel free to leave a review on Apple Podcasts and share the show!Follow us on Social Media...Instagram: DrSadafobgynTikTok: DrSadafobgyn

Expert Voices Join the Body & Soul Journey Candace Cameron Bure and Lisa Whittle have spent this season diving deep into what it means to live whole—body and soul. Now, Candace takes the conversation further with special guests who bring expert insight and personal testimony to nutrition and women's health. In this short update, Candace shares what's coming next: four powerful episodes featuring OB-GYN Dr. Tabatha Barber and nutritional health coach Vince Pitstik. Together, they'll unpack hormones, nutrition, and the spiritual connection to caring for our bodies. Candace also gives a behind-the-scenes peek at her newest project—Rise and Renew, a 30-day devotional journey available this fall. ·  

What happens when your calling to care for women collides with a culture that pressures you to compromise your convictions? In this episode, host Bill Reichart sits down with OB‑GYN Dr. Madison Chapman for a candid exploration of the ethical minefields facing Christian physicians today. From abortion training mandates to residency pressures, they unpack the daily dilemmas of caring for women and their babies while holding fast to the Gospel—and reveal how to navigate that tension without losing your soul.

What if I told you that 75% of women with PCOS may be struggling with hidden symptoms and most haven't even been diagnosed yet? In this episode, celebrity OB/GYN Dr. Thais Aliabadi and women's health advocate Mary Alice from the SheMD podcast are back to reveal what truly moves the needle for PCOS. You'll get a step-by-step breakdown of the lifestyle shifts, nutrition tweaks, supplement strategies, and up-to-the-minute medical options (from Metformin to GLP1s and beyond) that work for REAL, busy women navigating PCOS. We're talking how to advocate for yourself at the doctor's office, what tests truly matter, and why your mood, gut, and hormones are all connected (plus, why that matters for YOU).You'll walk away knowing exactly how to take control instead of feeling lost, with new confidence in understanding your body and relief that you are on the right path to heal. Ready to find out the next step you might be missing—one that could finally make the difference? Hit play and let's dive in.3:23 – Why “Healthy Lifestyle” Isn't Just a Buzzword—It's the First Line of PCOS Treatment4:12 – The Surprising Reason Walking After Every Meal Is A Game-Changer for Your Symptoms4:34 – How Insulin Resistance Drives PCOS and What Really Works to Manage It4:50 – The Real Deal on Metformin Dosing for PCOS (Most People Start Too Low)5:27 – Supplements, Birth Control, or IUDs? What to Consider If You're Struggling With Mood Swings6:48 – Why Chronic Inflammation Deserves Your Attention and the Antioxidants That Can Help7:10 – The Link Between Stress, Adrenal PCOS, and That Stubborn Acne or Hair Growth8:28 – Stubborn Skin and Hair Symptoms: Why Patience Is Key and What Really Helps8:45 – The Overlooked Mental Health Side of PCOS And Why PMDD Isn't “Just PMS”10:12 – GLP1s, Weight, and PCOS: How Medications Can Be Game-Changers (and What to Know Before You Start or Stop)11:16 – Why Losing Weight Isn't the Only PCOS Fertility Barrier (And What to Do If You're Still Struggling)13:27 – How PCOS and Endometriosis Are More Connected Than You Think And What Most Doctors Miss14:46 – Egg Count 101: Why Every Woman (Even in Her 20s or 30s) Needs to Know Her Number19:38 – Why Women's Symptoms Get Dismissed And How You Can Advocate for Yourself at the Doctor23:36 – The One Must-Do If Your Appointment Is Only 15 Minutes: Walking In With a Clear ListEpisode Links:Take the Ovii PCOS Quiz by Dr. Thais AliabadiLearn more about Ovii: Website | InstagramConnect with Dr. Thais Aliabadi: Website | InstagramConnect with Mary Alice: InstagramCheck out their podcast: SHE MD Podcast | InstagramOther Episodes You'll Love:Episode 121: Dismissed By Your Doctor? Here's How to Finally Get Answers About Your PCOS with Dr. Thais Aliabadi & Mary Alice Haney of SheMD Podcast

Dr. Jordan interviews Ob-Gyn Dr. Melissa Holmes, founder of the educational App Girlology, about educating girls and parents about puberty, periods, sexuality, and body image.Link to the Girlology App: https://girlology.com/Instagram @girlologyTo access free content for parents, Dr. Momfidence is our chatbot that will answer questions with content and resources that only come from Girlology and patient ed materials from some of our academic partners.Listeners can use this discount code for 20% off an annual subscription to the Girlology platform : ParentingGirlsPrevious Dr. Jordan podcast on girls & body image, interview with Dr. Ashleigh Gallagher & Dr. Janet Boseovski: I hate my body! When and why it starts and what parents can do about itFor more information about Dr. Jordan's books, camps, and other resources, check oujt his website at www.drtimjordan.comTo send comments or requests for future podcasts topics, email him at Anne@drtimjordan.comJoin Our Community:https://www.facebook.com/DrTimJordanhttps://www.instagram.com/drtimjordan/https://www.linkedin.com/in/tim-jordan-md-79799120b/

The internet is full of hype for products claiming to boost mood, reduce fatigue, and enhance sexual performance—including testosterone supplements. Low testosterone can affect both men and women, but OB/GYN Dr. George Arnold says supplements rarely raise hormone levels; only prescribed testosterone can.For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

September 23, 2025 ~ Full Show: Kevin is joined by OB/Gyn Dr. Jonathan Zaidan to learn more about the White House's announcement regarding a connection between Tylenol use and autism. Jennifer Hammond recaps the Lions game with Kevin. Don Barnes, co-founder of .38 Special calls into the show. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

OBGYN Dr. Jessica Vernon shares her journey into perinatal care, candid postpartum struggles, and collaborative work with midwives. She discusses perinatal mental health, realistic expectations, patient advocacy, and her book Then Comes Baby to help parents feel informed, supported, and less alone through pregnancy, birth, and postpartum. Find the Full Show Notes Here: https://www.enteringmotherhood.com/episodes Relevant Links: Register for the O.W.N Your Birth Childbirth Education Course Learn more about the Build Your Village Summit 5 ways to prepare for an Unmedicated Birth Download the FREE Comprehensive Birth Vision Planner Hypnobabies is a great tool to use hypnosis when preparing for childbirth. Use the code MOTHERHOOD20 to receive 20% off today! Truly fuel your body with FOND Bone Broth a verified regenerative by land to market company dedicated to serving you rich and handcrafted items. Use code ENTERINGMOTHERHOOD for 10% off. Looking to become a doula yourself and get into birthwork? Check out the Online Doula Training Program to get started on your path today. Become certified through Postpartum University and help clients learn more about how to nourish their bodies in the postpartum period. Want a baby carrier you can snuggle your baby tight in? Check out LoveHeld for their handwoven ring sling carrier you'll be sure to love. In need of nursing tops and postpartum items? Kindred Bravely is the place to shop for all of your attire needs and more.  Connect with Entering Motherhood: The Entering Motherhood Website @entering.motherhood (IG) Entering Motherhood (FB) Contact us Directly

Sex gets better with age...if we let it! In this episode, DB sits down with her mom, badass OBGYN Dr. Rebecca Levy-Gantt, to talk all about sex and aging, They get into responsive desire, menopause, hormones, vaginal estrogen (gamechanger!), and why more women than ever are asking for what they want in the bedroom. Plus: how to talk to your doctor about your pleasure! GUEST DETAILSDr. Rebecca Levy-Gantt is an obstetrician and gynecologist who has been taking care of women of all ages for more than thirty years. She is on LinkedIn, and her practice website is Premierobgynnapa.com. ABOUT SEASON 12 Season 12 of Sex Ed with DB is ALL ABOUT PLEASURE! Solo pleasure. Partnered pleasure. Orgasms. Porn. Queer joy. Kinks, sex toys, fantasies—you name it. We're here to help you feel more informed, more empowered, and a whole lot more turned on to help YOU have the best sex. CONNECT WITH US Instagram: @sexedwithdbpodcast TikTok: @sexedwithdbTwitter: @sexedwithdb Threads: @sexedwithdbpodcast YouTube: Sex Ed with DB SEX ED WITH DB SEASON 12 SPONSORS Lion's Den, Uberlube, & Magic Wand Get discounts on all of DB's favorite things here! GET IN TOUCH Email: sexedwithdb@gmail.comSubscribe to our BRAND NEW newsletter for hot goss, expert advice, and *the* most salacious stories. FOR SEXUAL HEALTH PROFESSIONALS Check out DB's workshop: "Building A Profitable Online Sexual Health Brand" ABOUT THE SHOW Sex Ed with DB is your go-to podcast for smart, science-backed sex education—delivering trusted insights from top experts on sex, sexuality, and pleasure. Empowering, inclusive, and grounded in real science, it's the sex ed you've always wanted. ASK AN ANONYMOUS SEX ED QUESTION Fill out our anonymous form to ask your sex ed question. SEASON 12 TEAM Creator, Host & Executive Producer: Danielle Bezalel (DB) (she/her) Producer: Sadie Lidji (she/her) Communications Lead: Cathren Cohen (she/her) Growth Marketing Manager: Wil Williams (they/them) MUSIC Intro theme music: Hook Sounds Background music: Bright State by Ketsa Ad music: Soul Sync by Ketsa and Soul Trap by Ketsa

We've been told that pain is just part of being a woman. That painful periods, mood swings, and feeling dismissed at the doctor's office are normal. But they're not, and SheMD is changing the story. In this conversation, I sit down with world-renowned OB-GYN Dr. Thais Aliabadi and fashion entrepreneur turned women's healthcare disruptor Mary Alice Haney, the co-founders of SheMD, a platform that is reshaping women's health from the inside out. They speak candidly on why so many women are misdiagnosed or ignored, the myths that have held us back for generations, and the real science behind conditions like PCOS and endometriosis. This episode is about unlearning what we've been taught and demanding better. Pain is a signal, not something we should have to live with.This episode is a wake up call for all women to be their own advocates, take your own notes, listen to what our bodies are telling us.This episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct, or indirect financial interest in products, or services referred to in this episodeThis episode is brought to you by the Clue App, Project Runway on Freeform, Venmo, Cakes Body, and Function Health. Clue is an invaluable health companion that meets you where you are. Visit helloclue.com and use code WITHWHIT at checkout for 90% off an annual Clue subscription.Project Runway is back in dramatic fashion! And the icon, Heidi Klum, returns to the mother of all fashion shows. Project Runway - July 31st on Freeform, stream on Hulu and Disney Plus.Venmo Everything with the Venmo Debit card. Visit Venmo.me/debit to learn more and sign up today.I've been wearing CAKES Body nonstop this summer - they're truly a game changer. To try them for yourself, go to cakesbody.com and use code WITHWHIT for 20% off your first order this summer. If you're ready to stop guessing and start knowing, learn more and join Function Health. The first thousand get a $100 credit toward their membership. Visit www.functionhealth.com/WITHWHIT or use gift code WITHWHIT100 at sign-up to own your health.Produced by Dear MediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Feeling off, anxious, or suddenly overwhelmed by hot flashes and mood swings? You're not imagining it—and you're not alone.In this episode of Baptist HealthTalk, OB/GYN Dr. Ingrid Paredes and primary care physician Dr. Emily Quintero break down what's really happening during perimenopause and menopause—from hormonal shifts and anxiety to weight gain, hot flashes, and more. They clear up common myths, explain what's normal (and what's not), and walk through a wide range of treatment options.Watch now to get real answers to the questions so many women have but don't always ask—and walk away feeling informed, empowered, and ready to take control of your health. Host:Johanna GomezAward-Winning Host & JournalistGuests:Ingrid Paredes, M.D. Obstetrician/GynecologistEmily Quintero, M.D.Primary Care PhysicianBaptist Health

Is it safe to travel while pregnant? In this episode of MamaDoc BabyDoc, Ob/Gyn Dr. Renda Knapp and pediatrician, Dr. Rachel Schultz break down everything you need to know before booking that trip during pregnancy. Whether you're planning a babymoon, heading to a family gathering, or traveling for work, we'll talk about when it's safe to go, when it's best to stay close to home, and what precautions you should take if you do hit the road. From trimester-specific tips to travel hacks that can keep you and your baby safe and comfortable, this episode is your go-to guide for navigating travel during pregnancy. Tune in for practical advice, up-to-date medical recommendations, and answers to the most common questions mamas-to-be are asking.

In this episode of the MamaDoc BabyDoc Podcast, OB/GYN Dr. Renda and her daughter, pediatrician Dr. Rachel, dig into one of the most talked-about—and often misunderstood—topics in childbirth: home birth vs hospital birth. We break down the actual data, risks, and benefits behind each setting. Who qualifies as a good candidate for home birth? What are the emergency backup plans? How do outcomes compare for moms and babies? We'll talk evidence, safety, and the importance of having a birth plan that matches your personal needs and medical reality. No judgment, just facts—with a dose of experience, compassion, and a few surprising insights along the way. Whether you're weighing your options or just curious, this one's for you.

In this must-listen episode of The Period Whisperer, I'm joined by Dr. Cheruba Prabakar, a board-certified OBGYN and minimally invasive surgeon, to talk about a crucial health topic for women in perimenopause: cervical cancer. Dr. Prabakar is here to shed light on the latest developments in cervical cancer screening, including the revolutionary self-collection HPV test—an FDA-approved, less invasive alternative to the traditional Pap smear.As we navigate the hormonal changes of perimenopause, understanding cervical cancer prevention and knowing how to get screened properly are vital steps in protecting our health. In this episode, Dr. Prabakar answers the questions you've been wondering about, from what causes cervical cancer to how you can take proactive steps for prevention. If you're a woman in perimenopause, this episode is packed with valuable information to help you take control of your health.Key Takeaways:

Welcome back to the MamaDoc BabyDoc Podcast! In this episode, OB/GYN Dr. Renda teams up with her daughter, pediatrician Dr. Rachel—who's pregnant with baby #2!—to dive into the fourth trimester: those raw, beautiful, and often overwhelming first three months after birth. We're talking about what your body really goes through postpartum, the emotional rollercoaster, newborn sleep (or lack of it), and why taking care of yourself is just as important as caring for your baby. Whether you're a first-time parent or adding to your crew, we're here with real talk, expert advice, and a whole lot of heart. ❤️ Grab a cup of tea (or a cold cup of coffee—we get it) and join us!

In this episode of Accelerated Health with Sara Banta, I'm joined by integrative OB/GYN Dr. Felice Gersh to discuss an important topic affecting millions of women: painful periods and hormonal birth control.We explore commonly overlooked conversations around:

Is your baby spitting up all the time—and you're not sure what's normal and what's not? In this episode of MamaDoc BabyDoc, pediatrician Dr. Rachel and OB/GYN Dr. Renda (who also happen to be daughter and mother!) break down baby reflux, spit up, and everything in between. From burping techniques to bottle feeding tips and signs of more serious conditions like GERD or pyloric stenosis, this episode is packed with practical advice, laughter, and reassurance for new parents navigating the messy (but usually harmless) world of baby spit up. In this episode of MamaDoc BabyDoc, Dr. Rachel and her mom Dr. Renda talk all things baby spit up—from what's totally normal to when you should be concerned. They explain the difference between reflux and GERD, share pro tips for burping and feeding, and walk through what symptoms might signal a bigger issue like food allergies or pyloric stenosis. Whether you're dealing with a refluxy baby or just drowning in extra laundry, this episode is here to help—with warmth, humor, and expert advice from two moms who've been there.

Dr. Hector Chapa is a practicing OBGYN who is involved in education at Texas A&M University's School of Medicine. He is also the host of a fun and engaging medical podcast, "Dr. Chapa's Clinical Pearls," that focuses on women's healthcare. In this episode, Dr. Chapa shares his path through medicine touching on the importance of passion in medicine and the shifting landscape of reproductive rights and access to care in Texas.

Have you ever wondered where your libido went? In this episode we do a deep dive on sexual slumps, low libido and lack of sexual desire that is frustrating (lack of desire that is not frustrating is not a problem!). We get to have this conversation first from the lens of Emmy-winning journalist Tamsen Fadal whose journey with low libido started in perimenopause and peaked on her honeymoon! From hot flashes and brain fog in the newsroom to bedroom low sex drive, Tamsen has become treasured for pulling back the curtain on midlife like never before. In this honest and empowering episode, menopause advocate Tamsen joins Shan for a conversation about menopause, sex drive and embracing life's shifts. Tamsen shares how a one-word note from her doctor "menopause...?" set off a journey she wasn't prepared for, and how that diagnosis impacted her body, her identity, and her intimacy. From tough talks with her husband to the quiet shame so many women carry through midlife transitions, Tamsen reminds us that getting older isn't the end of our sensual selves, it can actually be the beginning. In part two of this episode we are giving you a MasterClass on low libido led by three doctors: OBGYN Dr. Mickey, lifestyle medical physician Dr Lean AND Pelvic Floor expert Dr. Janelle Frederick aka the Vagina Rehab Doctor. This is a highlight of our hour and fifteen convo if you'd like to listen to the rest go to Loversbyshan.com/community  Follow Tamsen on Instagram https://www.instagram.com/tamsenfadal Get her book How to Menopause Listen to her podcast The Tamsen Show Checkout her website https://www.tamsenfadal.com/ 

Struggling with heavy periods, pelvic pain, or fibroids? You're not alone—and you have options. In this episode of Baptist HealthTalk, OB/GYN Dr. Ingrid Paredes explains the symptoms, causes and treatments behind some of the most common (and misunderstood) women's health issues, including endometriosis, fibroids and hysterectomies. You'll get real answers to the questions so many women have but don't always ask—and walk away with the knowledge to make confident decisions about your care. Watch now and take the first step in advocating for your health.Host:Neki Mohan, Award-Winning Journalist Guest:Ingrid Paredes, M.D., Obstetrician/Gynecologist

Rural hospital CEO Kevin Stansbury talks about what the Medicaid cuts being debated by lawmakers could mean to his 25-bed county-owned hospital in Hugo, Colorado. Then, Health Secretary Robert F. Kennedy Jr. announced on Tuesday that the CDC would no longer recommend the COVID-19 vaccine for healthy children or healthy pregnant women. OBGYN Dr. Linda Eckert weighs in. And, landmark climate legislation from the Biden administration would be dismantled in the massive spending bill that House Republicans recently passed. Grist's Zoya Teirstein breaks down the potential impacts on renewable energy projects already underway.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

OBGYN Dr. Bill Lile shares information about a new study that reveals the significant risks associated with the abortion pill. He and Robyn Chambers, Focus on the Family’s Vice President of Advocacy for Children, promote the incredible alternatives to abortion, informing women to pregnancy health centers for compassionate help. They also discuss the successes of Option Ultrasound and the abortion reversal pill to save babies. Honor the moms in your life this month by helping to rescue 11,800 babies and their mothers from abortion by May 31. Just $60 saves a life through the Option Ultrasound program. Get More Episode Resources If you've listened to any of our podcasts, please give us your feedback.

In this powerful and emotionally charged broadcast, Tara addresses listener reactions to her ongoing warnings about the COVID-19 vaccine and the censorship she faced while trying to speak out. She shares personal family struggles, including her father's health issues post-vaccine, and plays explosive testimony from OB-GYN Dr. James Thorp on adverse pregnancy outcomes tied to the shot. The episode also shifts focus to rising antisemitism and left-wing extremism on college campuses, linking recent attacks to radical ideologies. Tara connects the dots between government institutions, media suppression, and a growing threat to both Jewish communities and the broader American way of life. A raw, unfiltered episode filled with revelations, outrage, and calls for accountability.

#842: Join us as we sit down with the hosts of SHE MD  – world renowned OBGYN Dr. Thaïs Aliabadi, “Dr. A,” & women's advocate and influencer, Mary Alice Haney. This powerhouse duo brings unfiltered, impactful conversations to the SHE MD podcast with celebrity guests & today's top experts, covering essential women's health topics like menopause, PCOS, endometriosis, & fertility – on a mission to empower women with the knowledge & tools they need to become their own best health advocates. In this episode, Dr. A & Mary Alice take a deep dive into the challenges & implications of PCOS & endometriosis, highlight the importance of early mammogram screenings, & create a roadmap for women struggling with health issues.They also break down the growing conversation around weight loss medications such as ozempic & provide actionable early detection resources for breast cancer & PCOS – continuing their mission to drive awareness, education, & advocacy in women's health!   To Watch the Show click HERE   For Detailed Show Notes visit TSCPODCAST.COM   To connect with SHE MD click HERE   To connect with Dr. Thaïs Aliabadi click HERE   To connect with Mary Alice Haney click HERE   To connect with Lauryn Bosstick click HERE   To connect with Michael Bosstick click HERE   Read More on The Skinny Confidential HERE   Get your burning questions featured on the show! Leave the Him & Her Show a voicemail at +1 (512) 537-7194.   This episode is brought to you by The Skinny Confidential   Head to the HIM & HER Show ShopMy page HERE and LTK page HERE to find all of Michael and Lauryn's favorite products mentioned on their latest episodes.   To learn more about SHE MD and take their risk assessment tests visit shemdpodcast.com.   Join us on May 17th in Los Angeles for The Dear Media Edit, a live wellness experience with your favorite hosts and top voices in health and wellness—tickets available now at DearMedia.com/events.   This episode is sponsored by SmartMouth Find SmartMouth at Walgreens, Walmart, Amazon or visit smartmouth.com/skinny to snag a special discount on your next SmartMouth purchase.   This episode is sponsored by Squarespace Go to Squarespace.com for a free trial, and when you're ready to launch, squarespace.com/SKINNY to save 10% off your first purchase of a website or domain.   This episode is sponsored by Cymbioktika Go to Cymbiotika.com/TSC to get 20% off plus free shipping.    This episode is sponsored by Just Thrive Go to JustThrive.com and use code TSC for 20% off your first order.   This episode is sponsored by Fatty15 Fatty15 is on a mission to replenish your C15 levels and restore your long-term health. You can get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/SKINNY and using code SKINNY at checkout.   This episode is sponsored by Spritz Society Spritz Society is now available everywhere! Head to spritzsociety.com to find a store near you, and make sure to follow @spritz on Instagram for all their latest announcements and upcoming events. Spritz Society, Summer Starts Here!   Produced by Dear Media

“It takes more than hormones to fix our hormones.” - Dr. Anna CabecaWhen it comes to vaginal health, pelvic floor health, and incontinence issues, hormones play a critial role. From the type of hormones to oral formulations, injections, and topicals, there are a lot of options for hormone therapy, from the delivery vehicle to the forms of hormones used.At the same time, you can't optimize hormone health through hormone replacement only. We have to take a holistic picture, starting with the gut, lifestyle, and stress management. This approach enables the body to resuscitate, repair, and rejuvenate itself, allowing it to function at its peak. At this point, hormone therapy can offer a complementary supporting role, increasing the opportunity for optimal health and wellness.Today's guest, triple board-certified OB-GYN Dr. Anna Cabeca, has been working with women in midlife for decades, and she's an advocate for a holistic approach to hormone support, which she calls hormone replenishment.In this episode, Dr. Anna and I discuss when to start thinking about supporting your hormones, the connection between gut health and hormone balance, the need for personalized treatment appraoches, detoxification pathways, and the use of topical hormones, Dr. Cabeca's products for women in midlife, how her patients have improved their vaginal health and reversed incontinence in post-menopause, and more.Enjoy the episode, and let's innovate and integrate together!---Learn more or watch the video version of this conversation at https://integrativewomenshealthinstitute.com/getting-nerdy-about-hormones-topical-transdermal-oral-oh-my-with-dr-anna-cabeca-do/.Connect with me and access our entire platform at IntegrativeWomensHealthInstitute.com (https://integrativewomenshealthinstitute.com/). Find and follow us @integrativewomenshealth on YouTube (https://www.youtube.com/@integrativewomenshealth) and Instagram (https://www.instagram.com/integrativewomenshealth/).

Send us a textWhat happens when your doctor becomes your fiercest advocate — and ultimately, your friend?In this episode, I sit down with my own OB/GYN, Dr. Kimberly Shepherd — a true BADASS woman who has single handily helped so many women like me along their infertility and pregnancy journeys.I open up publicly about choosing egg donation — a topic that still feels taboo for so many. Dr. Shepherd and I get real about what it means to build a family outside the “traditional” mold, and why love — not biology — is what defines parenthood.We cover everything from: 

What if your hormones weren't the problem, but the result of a deeper imbalance?In this episode, we chat with hormone expert and triple board-certified OB-GYN Dr. Anna Cabeca, author of The Hormone Fix. Together, we explore how burnout, grief, and everyday stressors silently impact our hormones and why oxytocin, connection, and joy may be the missing piece.Dr. Anna shares her personal journey through infertility, early menopause, and deep personal loss—and how she rebuilt her health from the inside out. This conversation is a powerful reminder that healing isn't just about lab tests and supplements. It's about play, presence, and honoring your body's natural rhythms.You'll learn:Why stress and cortisol are at the root of so many hormone symptomsThe connection between oxytocin, joy, and hormonal balanceHow trauma, loss, and grief can change your physiology—and how to healWhy your urine pH might be the easiest health tool you're not usingSimple daily shifts that create more energy, ease, and hormonal harmonyRESOURCES:Grab my favorite red light - The Glow Light by Sauna Space: https://sauna.space/inspired Use code INSPIRED for 10% off!Take the Free Hormone Quiz: https://drannacabeca.com/pages/hormone-toxicity-questionnaire Join the Girlfriend Doctor Community: https://drannacabeca.com/products/the-girlfriend-doctor-club-membership-monthly Try Dr. Anna's Ketone + pH Test Strips: https://drannacabeca.com/products/dr-anna-cabeca-keto-alkaline-weight-loss-solution-urinalysis-test-strips?uid=11&oid=1&affid=8101936&creative_id=3 Read The Hormone Fix: https://amzn.to/4kqwH7m Connect with Dr. Anna: Website: https://drannacabeca.com/ Instagram: https://instagram.com/thegirlfrienddoctor****************If you're not getting my emails, make sure you head over here and sign up! I'll share goodies you can't get anywhere else, so you're missing out if you're not on the list! If you enjoyed this episode, would you please leave a review on whatever platform you use for podcasts? It really helps spread the word and inspire other moms. If you have a moment to spare, those reviews mean the world to me. Thank you!Follow Dr. Melissa:▶︎ YouTube▶︎ Facebook▶︎ Instagram▶︎ TikTok▶︎ WebsiteEpisode webpage: https://beinspiredmama.com/76

With the Wind with Dr. Paul – Show 172: Pediatric Perspectives – Nutrition for Moms: Preconception and Early Pregnancy with Scott Hankinson, M.D. Presenters: Dr. Paul Thomas, Scott Hankinson, M.D. Length: Approximately 34 minutes Web Resources Discussed: VAX FACTS Book (Paperback): https://indiepubs.com/products/vax-facts/ VAX FACTS Book (Signed Author's Copy): https://www.kidsfirst4ever.com/store/p10/Personalized_and_Signed_Author%E2%80%99s_Copy_of_VAXFACTS%E2%80%93_What_to_consider_before_vaccinating_at_all_ages_and_all_stages_of_life.html Happy Bugs by Erin Hankinson and Dr. Scott Hankinson: https://www.amazon.com/Happy-Bugs-Erin-Hankinson/dp/B0BQXW571C Whole Foods Health – YouTube Pregnancy Series: https://www.youtube.com/@Wholefoodshealth Doctors and Science: https://www.doctorsandscience.com/ Kids First 4Ever: https://www.kidsfirst4ever.com/#/ Key Points (with time stamps): 00:00:40 – Dr. Paul's Intro: Dr. Paul introduces the VAX FACTS book and how to get your signed copy. 00:01:35 – Show Introduction: Dr. Paul previews a vital conversation on preconception and early pregnancy nutrition with OB-GYN Dr. Scott Hankinson. 00:03:03 – Nutrition and the Microbiome: Dr. Hankinson describes the profound impact of a diverse, high-fiber diet on both mom and baby's long-term health. 00:06:00 – Epigenetic Effects: Nutrition choices today can positively or negatively influence generations to come. The research shows it, and Dr. Hankinson breaks it down. 00:07:57 – The Vitamin D Connection: Discover how keeping vitamin D levels above 50 ng/mL can help prevent pregnancy complications like preeclampsia and miscarriage. 00:10:25 – Teaching Kids Gut Health: Dr. Hankinson shares his new children's book, Happy Bugs, which helps kids understand gut flora and the importance of a healthy microbiome. 00:12:18 – Caution Around Pregnancy Vaccines: Dr. Hankinson joins Dr. Paul in calling for true informed consent, raising concerns about the safety and necessity of Tdap, flu, RSV, and COVID shots during pregnancy. 00:15:22 – What Every Parent Should Ask: Before consenting to any intervention, Dr. Hankinson urges families to ask: “Where is the safety data?” Summary: In this empowering Pediatric Perspectives episode, Dr. Paul welcomes OB-GYN and educator Dr. Scott Hankinson for a critical discussion about the foundational role of nutrition during preconception and early pregnancy. They unpack the latest data on epigenetics, gut health, and vitamin D, while sounding the

Ep 141 Description:  “You are the expert on you. So trust your own expertise when you bring that to the conversation. Don't let anybody talk you out of your own expertise.” —Dr. Nicole Rankins   Your voice matters in the birth room!  Too often, women's preferences and concerns are overlooked or dismissed during hospital births. But we can reclaim our power by understanding the foundation for a positive, empowered birth experience.  Dr. Nicole Rankins is a Board Certified OB GYN, maternal health advocate, and creator of one of the top 0.5% global podcasts on pregnancy and birth, with over 2.6 million downloads. Her expertise and accessible approach have empowered thousands of women to approach birth with confidence. Tune in as Debra and Dr. Nicole discuss the must-knows of childbirth education, preparing for birth without overwhelm, creating birth plans that actually work, and expert advice for an empowered hospital birth experience.   Connect with Debra! Website: https://www.orgasmicbirth.com  Instagram: https://www.instagram.com/orgasmicbirth X: https://twitter.com/OrgasmicBirth  YouTube https://www.youtube.com/c/OrgasmicBirth1  Tik Tok https://www.tiktok.com/@orgasmicbirth  Linkedin: https://www.linkedin.com/in/debra-pascali-bonaro-1093471    Episode Highlights: 03:32 First Birth: A Traumatic C-Section 07:59 The Importance of Childbirth Education  10:17 Green Flags, Red Flags 16:22 Birth Plans and Preferences    21:40 Informed Decision-Making in Labor 24:47 Creating a Joyful Birth Experience     Resources: 

If you're on the fence if (and how) you should test yourself during peri and post menopause, this is the episode for you. Ob/Gyn Dr. Anna Cabeca sets the records straight and gives us her opinion on the top questions most asked during this phase of life.   We cover: Hormone testing and even more important markers to test When is the best time to test sex hormones? Problems with interpreting blood tests Which urine tests are best for testing hormone metabolites? Hormones as energetic messengers How her patients screen for breast cancer Do mammograms increase the risk of breast cancer? How to offset radiation from testing and flying How to regulate insulin and blood sugar Is vaginal progesterone better than creams and oral? What is vaginal dysbiosis? What to combine progesterone with for better results Is vaginal estrogen really not systemic? The best place to rub your hormone creams Can you use estrogen creams on your face? What FSH levels should be to protect bones Why DIM is better than indole 3 carbinol for estrogen detoxification   Dr. Anna Cabeca has a private practice in Dallas Texas and has helped over 10,000 women — and millions more through her books, online videos and articles -- for 20+ years. She likes to combine modern medicine and time-tested natural remedies that give proven realistic solutions to women dealing with menopausal health challenges so that they can lead the life they want, need, and deserve. She is not only double, but triple board certified and a Fellow of Gynecology and Obstetrics, Integrative Medicine, Anti-aging and Regenerative Medicine. Certified in Functional medicine, sexual health, and bioidentical hormone replacement therapy, Dr. Cabeca wrote the bestseller The Hormone Fix, Keto-Green 16, MenuPause and has been featured in Forbes, People magazine, Mind Body Green, ABC, NBC, CBS. Use discount code ZORA - 10% off first order Magic Menopause Program: https://order.magicmenopause.com/ Mighty Maca: https://drannacabeca.com/collections/maca Julva (DHEA) vaginal cream: https://drannacabeca.com/products/julva Balance (progesterone) cream: https://drannacabeca.com/products/pura-balance-ppr-cream   PAST EPISODE https://hackmyage.com/improve-sexual-function-libido-utis-dryness-anna-cabeca/   Contact Dr. Anna Cabeca https://drannacabeca.comhttps://www.facebook.com/DrAnnaCabeca https://www.instagram.com/thegirlfrienddoctor Give thanks to our sponsors: Qualia senolytics and brain supplements. 15% off with code ZORA here.  Try BEAM minerals at 20% off with code ZORA here. Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Get Mitopure Urolithin A by Timeline. 10% discount with code ZORA at https://timeline.com/zora Try OneSkin skincare for with code ZORA at https://shareasale.com/r.cfm?b=2685556&u=4476154&m=102446&urllink=&afftrack= Join ⁠⁠⁠Biohacking Menopause⁠⁠⁠ before April 1, 2025 to win Theranordic Daily Healthy Fibre and Optimized Enzymes. First 5 new members win! 10% off with code ZORA at theranordic.com. https://biohacking-menopause.mn.co   Join the Hack My Age community on: Facebook Page : ⁠⁠⁠⁠⁠@⁠Hack My Age⁠ Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠   Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠   Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠    ⁠Membership group: Biohacking Menopause⁠  Email: zora@hackmyage.com This podcast is edited by ⁠⁠⁠⁠⁠jonathanjk@gmail.com

Ladies, we need to talk—about hormones, periods, and the stuff no one tells you. This week, we're joined by top OBGYN Dr. Nada Alibrahim to break down PCOS and endometriosis, two conditions that impact way more women than you think. Painful cycles? Random weight gain? Mood swings from hell? It might not be just your hormones. We're debunking fertility myths, tackling cultural taboos, and even giving you the ultimate guide to fasting during Ramadan with PCOS. All this and more in this week's episode!

IVF is WRONG! w/ OBGYN Dr. CudihySupport the show

Few policy debates received more attention in last November's election than reproductive freedom. Strangely, however, despite widespread evidence that significant majorities favor abortion rights and the right to contraception — see for example the results of numerous ballot initiatives — Republicans opposed to reproductive freedom managed to win the presidency and control of the new […]

Dr. Hoffman continues his conversation with ObGyn Dr. Anna Cabeca, author of "MenuPause: Five Unique Eating Plans to Break Through Your Weight Loss Plateau and Improve Mood, Sleep, and Hot Flashes." 

Menopause can pose severe challenges to women: hot flashes, cognitive impairment, sleep problems, and sexual difficulties, often compounded by weight gain. ObGyn Dr. Anna Cabeca is schooled in mainstream medicine but has added a natural medicine repertoire to her practice. She recounts how she learned to overcome her own devastating symptoms of early menopause. She believes that diets need to be individualized for menopausal women. Find her quiz to determine your menopause type at www.DrAnna.com/mpquiz. We discuss the role of supplements and bio-identical hormone replacement to augment tailored diets. Her book, "MenuPause: Five Unique Eating Plans to Break Through Your Weight Loss Plateau and Improve Mood, Sleep, and Hot Flashes," highlights the role variations on the keto diet and intermittent fasting can play in alleviating menopause symptoms and reversing mid-life weight gain. 

This week, Tay returns for another girl-talk episode with the dynamic duo behind the SHE MD Podcast! World-renowned OBGYN Dr. Thaïs Aliabadi and women's health advocate Mary Alice Haney share the story of how they met and what inspired their passion for creating a podcast focused on women's health. We dive deep into polycystic ovary syndrome (PCOS), discussing what it is, how it's diagnosed, and its root causes. The conversation also covers PCOS diets, their new business Ovii and its innovative PCOS supplement, along with their thoughts on birth control's impact on the body. We also tackle the buzz around Ozempic and its relevance for PCOS management, plus they offer empowering advice for women to advocate for themselves!Be sure to follow Dr. Thaïs Aliabadi https://instagram.com/drthaisaliabadi/, Mary Alice Haney https://instagram.com/haneyofficial/, SHE MD Podcast https://instagram.com/shemdpodcast/, and Ovii https://instagram.com/oviihealth/!Check out the SHE MD podcast here: https://www.shemdpodcast.com/Check out Ovii and their PCOS supplement here: https://ovii.com/To email us your questions or share your story, you can reach out to lautner.thesqueezepodcast@gmail.comBe sure to rate, review, and follow the podcast so you don't miss an episode! Plus, follow us on Instagram:The Squeeze: https://instagram.com/thesqueeze/Tay Lautner: https://instagram.com/taylautner/Taylor Lautner: https://instagram.com/taylorlautner/& TikTok: https://tiktok.com/@thesqueezepodcastTo learn more from The Lemons Foundation, follow https://instagram.com/lemonsbytay/ and visit lemonsbytay.comEpisode Sponsors:Take the online quiz and introduce Ollie to your pet. Visit Ollie.com today for 60% off your first box of mealsPut your water to work with Gatorade Hydration Booster.Produced by Dear MediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

There are many options for birth control after childbirth—from short-term contraception to long-term or permanent options. Determining the right choice is hard—we have to weigh out factors like whether we want more children, whether or not we're breastfeeding, and how our body responds to hormones. This week on The Momwell Podcast, I'm joined by OB-GYN Dr. Fran Haydanek, founder of Paging Dr. Fran, to discuss how moms can make informed decisions about birth control after childbirth.Show Notes: https://bit.ly/3TZQqPx Book a free 15 minute consultation with a mom therapist: momwell.com Follow Momwell on Instagram: instagram.com/momwell Sign up for our weekly VIP Newsletter: momwell.com/newsletter Browse our popular guides and courses: momwell.com/shop Learn more about your ad choices. Visit megaphone.fm/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

OB/GYN Dr. Liz Lyster joins Stacy to educate us about the role of hormones in aging and menopause, why we all may be experiencing "bursts" of aging in our mid-40s and early 60s, and why women must continue to advocate for themselves during these changes. Find Dr. Liz Lyster: DrLizMD.com Facebook.com/drlizlyster Instagram.com/drlizlyster Linkedin.com/in/drlizmd Youtube.com/c/DrLizLyster Don't forget to subscribe to this channel and visit realeverything.com! If you haven't yet unlocked ad-free content, checkout patreon.com/thewholeview. Your subscription goes to support this show and gets you direct access to submit your questions! We also want to give a big thank you to this week's sponsor! Paleovalley.com/wholeview | Get 15% off your first order! Learn more about your ad choices. Visit megaphone.fm/adchoices

Glenn tells the story of the godfather of artificial intelligence and discusses the dangers of AI advancing far beyond society's expectations. BlazeTV host of "Fearless" Jason Whitlock joins to discuss the chances of a Trump conviction and President Biden's latest race-baiting speech. OB-GYN Dr. John Bruchalski joins to discuss the evils of abortion, particularly within marginalized communities, and shares personal stories on the graphic nature of abortion. Learn more about your ad choices. Visit megaphone.fm/adchoices

Glenn tells the story of the godfather of artificial intelligence and talks about the dangers of AI advancing far beyond society's expectations. Did ChatGPT steal the voice of actress Scarlett Johansson after she turned the service down? Glenn and Stu discuss what this type of technological advancement will lead to. BlazeTV host of "Fearless" Jason Whitlock joins to discuss the downfall of rapper Diddy and how he embodies the nihilistic culture he normalized through his music. Glenn and Jason also dissect the chances of a Trump conviction and the latest race-baiting speech made by President Biden. OB-GYN Dr. John Bruchalski joins to discuss where the pro-life movement currently stands and what needs to be done. Dr. Bruchalski also speaks about the evils of abortion, particularly within marginalized communities, and shares personal stories on the graphic nature of abortion. Learn more about your ad choices. Visit megaphone.fm/adchoices